drugset / Trial / NCT01490788
A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.
RandomizedCrossoverOpen-labelTreatment
Summary
The trial is designed to assess the safety and tolerability of TNX-102 2.4 mg and to compare the bio-availability of TNX-102 2.4 mg and cyclobenzaprine 5 mg tablets under fasting or fed conditions.
Timeline
- Start
- 2011-11-18
- Primary completion
- 2011-12-30
- Completion
- 2011-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cyclobenzaprine | Small molecule | 2.4 mg | — |
| Subject | cyclobenzaprine | Small molecule | 5 mg | — |
Indications
No indication recorded.